School personnel information

写真b

Shiraiwa Toshihiko


Organization 【 display / non-display

  • 2016.04.01 - , Division of Medicine, Graduate School of Medicine, Associate Professor

 

Academic Papers 【 display / non-display

  • Clinical backgrounds associated with discrepancy between subjective and objective assessments of medication adherence in Japanese type 2 diabetic patients., Takahara M, Shiraiwa T, Ogawa N, Katakami N, Matsuoka TA and Shimomura I., Diabetol Int.,7;398-403, 2016.12, Papers

  • Preference in time of insulin injection in type 2 diabetic patients treated with once-daily long-acting insulin analog., Takahara M, Shiraiwa T, Katakami N, Matsuoka TA and Shimomura I., Diabetes Obes Metab.,18;1098-9, 2016.11, Papers

  • Variations in the associations of taste-related words with foods in diabetic patients in Japan according to Gender, age, and geographic variation in association of taste-related words with foods in diabetic patients in Japan: a multicenter study conducted in seven regions of Japan., Takahara M, Shiraiwa T, Abe K, Ishimaru Y, Iwamoto M, Shimizu M, Tomonaga O and Yokoyama H., Diabetol Int.,7;314-320, 2016.09, Papers

  • Sitagliptin attenuates the progression of carotid intima-media thickening in insulin-treated patients with type 2 diabetes mellitus: The Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE): a randomized controlled trial., Mita M, Katakami N, Shiraiwa T, Yoshii H, Onuma T, Kuribayashi N, Osonoi T, Kaneto H, Kosugi K, Umayahara U, Yamamoto T, Matsumoto K, Yokoyama H, Tsugawa M, Gosho M, Shimomura I, Watada H, Diabetes Care,39(3);455-464, 2016.03, Papers

  • Alogliptin, a dipeptidyl peptidase-4 inhibitor, prevents the progression of carotid atherosclerosis in patients with type 2 diabetes mellitus: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A)., Mita M, Katakami N, Yoshii H, Onuma T, Kaneto H, Osonoi T, Shiraiwa T, Kosugi K, Umayahara Y, Yamamoto T, Yokoyama H, Kuribayashi N, Jinnouchi H, Gosho M, Shimomura I, Watada H, Collaborators on the Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A) Trial., Diabetes Care,39(1);139-148, 2016.01, Papers